Form D · Biotechnology
Metheor Therapeutics Corp
Shoreline, WA · CIK 0001528276
Offering snapshot reported Oct 30, 2015 · SEC filing
- Reported sold
- $90K Offering amount: $200K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 12, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2015 | Amendment | $90,000 | No comparison | 7 | SEC filing |
| Nov 12, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 30, 2011 | Initial | $185,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-228045
Source: Form D, filed Oct 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce L.A. Carter | Director |
| Robert Day | Director |
| Theo De Vos | Executive |
| Gary Schweikhardt | Director |
| R. Gary Schweikhardt | Director |
| Andrew Z. Sledziewski | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17736 15 Th Ave. Nw
Shoreline, WA, 98177
Shoreline, WA, 98177